NAT10 and cancer: Notably, many other enriched pathways were mitochondrial beta‐oxidation of long‐ and short‐chain FAs and FA elongation from mitochondria which were similarly identified in our previous study on metabolomic impact of Remodelin, a small molecular inhibitor of NAT10 on cancer cells.12